Article Details

Gene-Editing Cardiovascular Therapy Startup Licenses CRISPR Patents, Partners with Beam

Retrieved on: 2019-05-06 22:46:05

Tags for this article:

Click the tags to see associated articles and topics

Gene-Editing Cardiovascular Therapy Startup Licenses CRISPR Patents, Partners with Beam. View article details on hiswai:

Excerpt

<div>Verve was launched with $58.5 million in Series A financing led by GV (formerly <b>Google Ventures</b>), with participation by ARCH Venture Partners, ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up